- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07820514
Physical Exercise in Patients With Chronic Kidney Disease in Hemodialysis (Pehedal-ESKD) (Pehedal-ESKD)
Physical Exercise in Hemodialysis Patients in End Stage Kidney Disease
The goal of this clinical trial is to learn whether different types of exercise performed during hemodialysis are safe, well tolerated, and beneficial for adults receiving maintenance hemodialysis. The main questions it aims to answer are:
- Are aerobic exercise using a cycle ergometer and resistance exercise using elastic bands well tolerated during hemodialysis?
- Do these exercise programs improve physical function, body composition, quality of life, and dialysis-related outcomes compared with standard care?
Researchers will compare aerobic exercise, resistance exercise, and standard hemodialysis care to evaluate differences in tolerance and health outcomes.
Participants will:
- Be assigned to one of three groups: cycle ergometer exercise, elastic-band resistance exercise, or standard care.
- Attend hemodialysis sessions as scheduled.
- Complete physical performance and body composition assessments at baseline and after 6 months.
- Complete questionnaires about health and quality of life.
The results of this study may help identify effective exercise strategies to improve health and well-being in people receiving long-term hemodialysis treatment.
Přehled studie
Postavení
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Ersilia Satta, PhD MD
- Telefonní číslo: +39 3395703091
- E-mail: e.satta@consorzionefrocenter.it
Studijní místa
-
-
-
Torre del Greco, Itálie, 80059
- Nábor
- NefroCenter Dialysis Centers
-
Kontakt:
- Study Coordinator, PhD
- Telefonní číslo: +39 3395703091
- E-mail: e.satta@consorzionefrocenter.it
-
Vrchní vyšetřovatel:
- Ersilia Satta, PhD MD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Age ≥18 years.
- Receiving maintenance hemodialysis for more than 3 months.
- Clinically stable condition.
- Ability and willingness to provide written informed consent.
Exclusion Criteria:
- Unstable angina.
- Uncontrolled hypertension.
- Any medical condition judged by the treating nephrologist to contraindicate or make intradialytic exercise unsafe
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Cycle ergometer
Participants performed supervised intradialytic aerobic exercise using a cycle ergometer during the first 2 hours of hemodialysis sessions.
Exercise was conducted three times per week for a total of 150 minutes per week at moderate intensity, corresponding to a Borg Rating of Perceived Exertion of 12-13.
Training sessions were supervised by qualified exercise professionals and monitored by dialysis nurses to ensure safety and adherence.
|
Participants performed supervised intradialytic aerobic exercise using a cycle ergometer during the first 2 hours of hemodialysis sessions.
Exercise was conducted three times weekly for a total of 150 minutes per week at moderate intensity (Borg Rating of Perceived Exertion 12-13).
Sessions were supervised by exercise professionals and monitored by dialysis nurses to ensure safety and adherence.
|
|
Aktivní komparátor: Elastic band resistance training
Participants performed supervised intradialytic resistance exercise using progressive color-coded elastic bands during the first 2 hours of hemodialysis sessions.
Training was conducted three times per week for a total of 150 minutes per week at moderate intensity and targeted both upper and lower limbs.
Resistance was progressively adjusted according to individual tolerance and correct exercise execution.
Sessions were supervised by exercise professionals and monitored by dialysis nurses.
|
Participants performed supervised intradialytic resistance exercise using progressive color-coded elastic bands during the first 2 hours of hemodialysis sessions.
Training was conducted three times weekly for a total of 150 minutes per week at moderate intensity and targeted both upper and lower limbs.
Resistance levels were progressively adjusted according to individual tolerance and proper exercise execution.
|
|
Žádný zásah: Control
Participants received standard hemodialysis care and continued their usual activities during dialysis sessions without participation in a structured intradialytic exercise program.
Clinical assessments and follow-up evaluations were performed according to the study protocol.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Incidence of intradialytic intolerance and hemodynamic instability
Časové okno: Baseline to 6 months
|
Exercise tolerability will be evaluated through the incidence of intradialytic intolerance events and the maintenance of hemodynamic stability during hemodialysis sessions.
Hemodynamic monitoring will include systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate measured before, during, and after exercise sessions.
Clinical signs and symptoms of exercise intolerance, including hypotension, dizziness, muscle cramps, nausea, premature interruption of exercise, or other adverse events occurring during dialysis, will be recorded.
Outcomes will be compared among cycle ergometer exercise, elastic-band resistance training, and combined exercise programs to assess the relative tolerability and safety of each intervention.
|
Baseline to 6 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Maximal workload during cycle ergometer stress testing
Časové okno: Baseline to 6 months
|
Changes in maximal workload achieved during cycle ergometer stress testing.
|
Baseline to 6 months
|
|
Six-minute walk test distance
Časové okno: Baseline and 6 months
|
Changes in distance covered during the 6-minute walk test as a measure of functional exercise capacity.
|
Baseline and 6 months
|
|
Step-test performance
Časové okno: Baseline and 6 months
|
Changes in step-test performance as an indicator of functional mobility and lower-limb performance.
|
Baseline and 6 months
|
|
Chair-stand test performance
Časové okno: Baseline and 6 months
|
Changes in the number of repetitions completed during the chair-stand test as a measure of lower-limb muscle function.
|
Baseline and 6 months
|
|
Handgrip strength
Časové okno: Baseline and 6 months
|
Changes in handgrip strength measured using a hand dynamometer.
|
Baseline and 6 months
|
|
Weekly exercise time
Časové okno: Throughout the 6-month intervention period
|
Changes in the total amount of exercise completed per week during the intervention period.
|
Throughout the 6-month intervention period
|
|
Fat-free mass and fat mass
Časové okno: Baseline to 6 months
|
Changes in fat-free mass and fat mass assessed by bioelectrical impedance analysis, both reported as percentage of body weight.
|
Baseline to 6 months
|
|
Bone mineral content
Časové okno: Baseline and 6 months
|
Changes in bone mineral content assessed by radiofrequency echographic multi-spectrometry (REMS).
|
Baseline and 6 months
|
|
Bone mineral status (T-score)
Časové okno: Baseline and 6 months
|
Changes in T-score as an indicator of bone mineral status.
|
Baseline and 6 months
|
|
Appendicular skeletal muscle mass index (ASMMI)
Časové okno: Baseline and 6 months
|
Changes in appendicular skeletal muscle mass index (ASMMI) as a measure of skeletal muscle mass.
|
Baseline and 6 months
|
|
Anthropometric circumferences
Časové okno: Baseline and 6 months
|
Changes in upper-limb, lower-limb, and trunk circumferences measured using standardized anthropometric procedures.
|
Baseline and 6 months
|
|
Health-related quality of life
Časové okno: Baseline to 6 months
|
Changes in health-related quality of life assessed using the Sarcopenia Quality of Life (SARQoL) questionnaire.
The SARQoL questionnaire generates an overall score ranging from 0 to 100, with higher scores indicating better quality of life.
|
Baseline to 6 months
|
|
Medication burden
Časové okno: Baseline to 6 months
|
Changes in the number of prescribed medications and antihypertensive drugs between baseline and follow-up.
|
Baseline to 6 months
|
|
Dialysis adequacy
Časové okno: Baseline to 6 months
|
Changes in dialysis adequacy expressed as Kt/V.
|
Baseline to 6 months
|
|
Dialysis session duration
Časové okno: Baseline and 6 months
|
Changes in the duration of the hemodialysis session (min).
|
Baseline and 6 months
|
|
Blood flow rate
Časové okno: Baseline and 6 months
|
Changes in blood flow rate (Qb) during hemodialysis.
|
Baseline and 6 months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 0079556CE
- CUP E63C22002050006 (Jiné číslo grantu/financování: National Recovery and Resilience Plan (PNRR), Age-It - Spoke 4)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .